| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 01/16/2003 | WO2003004502A1 Process for the preparation of tetrahydrothieno [3,2-c] pyridine derivatives |
| 01/16/2003 | WO2003004492A1 Isoxazolyl-pyrimidines as inhibitors of src and lck protein kinases |
| 01/16/2003 | WO2003004488A1 Indazole benzimidazole compounds as tyrosine and serine/threonine kinase inhibitors |
| 01/16/2003 | WO2003004480A2 Substituted piperazine and diazepanes as histamine h3 receptor agonists |
| 01/16/2003 | WO2003004028A1 Tetrahydroquinoline derivatives |
| 01/16/2003 | WO2003004027A1 Substituted anilinic piperidines as mch selective antagonists |
| 01/16/2003 | WO2003004023A1 1-alkyl-2-aryl-benzimidazole derivatives, their use for producing medicaments and pharmaceutical preparations containing said derivatives |
| 01/16/2003 | WO2003004020A1 Heteroaryl carboxylic acid amides, the production thereof and the use of the same as inhibitors of the microsomal triglyceride transfer protein (mtp) |
| 01/16/2003 | WO2002050062A3 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors |
| 01/16/2003 | WO2002046129A3 Inhibitors of histone deacetylase |
| 01/16/2003 | WO2002012196A3 Lactam compounds and their use as inhibitors of serine proteases and method |
| 01/16/2003 | US20030013895 Method for the preparation of 5-cyanophthalide |
| 01/16/2003 | US20030013889 Process for the preparation of taxane derivatives |
| 01/16/2003 | US20030013886 Such as (E)-1-(2-Pyridyl)-2-styryl-1H-benzimidazole; antiinflammatory and analgesic agents; prostaglandin inhibitors |
| 01/16/2003 | US20030013875 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
| 01/16/2003 | US20030013741 Antihistamines; antiallergens |
| 01/16/2003 | US20030013737 Antimicrobial quinolone derivatives and use of the same to treat bacterial infections |
| 01/16/2003 | US20030013730 Preventing diarrhea |
| 01/16/2003 | US20030013724 Novel prolines as antimicrobial agents |
| 01/16/2003 | US20030013713 Compounds as PDE IV and TNF-inhibitors |
| 01/16/2003 | US20030013712 Antiinflammatory agents |
| 01/16/2003 | US20030013708 Therapeutic heterocyclic compounds |
| 01/16/2003 | US20030013707 Enzyme inhibitor |
| 01/16/2003 | US20030013041 Write-once optical data carrier |
| 01/16/2003 | CA2454613A1 Substituted anilinic piperidines as mch selective antagonists |
| 01/16/2003 | CA2452603A1 Isoxazolyl-pyrimidines as inhibitors of src and lck protein kinases |
| 01/15/2003 | WO2002006233A1 1-aryl-4-alkyl halide-2(1h)-pyridones and their use as herbicides |
| 01/15/2003 | EP1275648A1 Epothilone minor constituents |
| 01/15/2003 | EP1275644A1 Benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them |
| 01/15/2003 | EP1275641A2 Benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them |
| 01/15/2003 | EP1275638A1 Combination therapy for the treatment of immunological disorders |
| 01/15/2003 | EP1274701A1 Chemical compounds |
| 01/15/2003 | EP1274683A2 Heterocyclic acylsulfimides, a method for their production, agents containing the same and their use as pesticides |
| 01/15/2003 | EP1274682A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 01/15/2003 | EP1274426A2 Use of thioamide oxazolidinones for the treatment of bone resorption and osteoporosis |
| 01/15/2003 | EP1169317B1 Triarylimidazoles |
| 01/15/2003 | EP1023265B1 Azetidinone derivatives for the treatment of hcmv infections |
| 01/15/2003 | EP0937057B1 Novel (-)-enantiomers of cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| 01/15/2003 | EP0925287B1 Heterocyclic metalloprotease inhibitors |
| 01/15/2003 | EP0820451B1 Novel heterocyclic compounds |
| 01/15/2003 | EP0790988B1 Use of dioxomorpholines to combat endoparasites, novel dioxomorpholines and process for their production |
| 01/15/2003 | EP0787723B1 Cyclopropachromenecarboxylate derivatives |
| 01/15/2003 | EP0729468B1 Non-peptide tachykinin receptor antagonists |
| 01/15/2003 | CN1391572A Oxazolidinones having sulfoximine functionality and their use as antimicrobial agents |
| 01/15/2003 | CN1391571A Heterocyclic compounds and their use as medicines |
| 01/15/2003 | CN1391563A Therapeutic quinazoline derivatives |
| 01/15/2003 | CN1391562A Quinazoline derivatives as pharmaceuticals |
| 01/15/2003 | CN1391558A Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use |
| 01/15/2003 | CN1391474A 5-membered heterocycle derivatives, production thereof and use as medicaments |
| 01/15/2003 | CN1391473A VLA-4 inhibitor compounds |
| 01/15/2003 | CN1098838C Substituted N-(indole-2-carbonyl)-beta-alanimamides and derivatives as antidiabetic agents |
| 01/15/2003 | CA2416192A1 1-aryl-4-alkyl halide-2(1h)-pyridones and their use as herbicides |
| 01/14/2003 | US6506901 1-(9H-Carbazol-4-yloxy)-3-((1-(7-trifluoromethyl-quinolin-4-yl) -piperidin-4-lmethyl)-amino)-propan-2-ol, for example; treating diabetes, urinary continence, atherosclerosis, gastrointestinal disorders, glaucoma |
| 01/14/2003 | US6506787 Aids therapy |
| 01/14/2003 | US6506781 Prevent formation of a hydrogen bond between the agonist and tyrosine or histidine, or tryptophan involved in receptor activation; and/or b) displace the tyrosine or histidine, or tryptophan involved in receptor activation from its agonist |
| 01/14/2003 | US6506757 Carboxylic acid derivatives and drugs containing the same as the active ingredient |
| 01/14/2003 | US6506754 Compounds as anticoagulants |
| 01/14/2003 | US6506750 Morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives |
| 01/14/2003 | US6506748 Aromatic heterocyclic compounds as antiinflammatory agents |
| 01/14/2003 | US6506747 Method of treating an inflammatory disease which comprises administering to a patient in need of such treatment-a N-(4-(5-Ethyl-3-pyridin-3-yl-pyrazol-1-yl)phenyl)pyridine-3-carboxamide; |
| 01/14/2003 | US6506744 Benzazepinone-derivatives |
| 01/14/2003 | US6506738 Treatment of viral infections. More particularly, the invention provides benzimidazolone derivatives for the treatment of respiratory syncytial virus infection. |
| 01/14/2003 | US6506708 3-(heterocyclyl)-benzoylpyrazole-derivatives |
| 01/14/2003 | US6506507 Methine compound, material for organic luminescence element, and organic luminescence element using the same |
| 01/14/2003 | CA2252543C Benzene derivatives substituted by heterocycles and herbicides |
| 01/09/2003 | WO2003002561A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 01/09/2003 | WO2003002560A1 New derivatives of oxazolidinones as antibacterial agents |
| 01/09/2003 | WO2003002559A2 Piperidine compounds for use as orexin receptor antagonist |
| 01/09/2003 | WO2003002558A1 Remedial agent for viral infectious disease |
| 01/09/2003 | WO2003002556A1 Novel heteroaryl derivatives, their preparation and use |
| 01/09/2003 | WO2003002553A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 01/09/2003 | WO2003002540A1 Cyclic diamine compound having five-membered cyclic group |
| 01/09/2003 | WO2003002532A1 Cyclic diamine compounds having fused-ring groups |
| 01/09/2003 | WO2003002531A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 01/09/2003 | WO2003002530A2 Pyrrolidines as dipeptidyl peptidase inhibitors |
| 01/09/2003 | WO2003002519A1 Phenol derivatives and their use in medicaments |
| 01/09/2003 | WO2003002147A1 Preventives/remedies for organ functional disorders and organ dysfunction |
| 01/09/2003 | WO2003002118A1 Substituted 8-arylquinoline pde4 inhibitors |
| 01/09/2003 | WO2002087587A3 4-aminosulfonylquinazolines and -quinolines as tyrosine kinase inhibitors |
| 01/09/2003 | WO2002059111A3 Pyrazole compounds useful as protein kinase inhibitors |
| 01/09/2003 | WO2002020436A3 Methods for forming combinatorial libraries combining amide bond formation with epoxide opening |
| 01/09/2003 | US20030009034 Transition metal mediated process |
| 01/09/2003 | US20030008901 For therapy of arthritis, cancer, and other diseases characterized by matrix metalloproteinase or mammalian reprolysin activity |
| 01/09/2003 | US20030008888 Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| 01/09/2003 | US20030008874 1,3 disubstituted pyrrolidines as alpha -2- adrenoceptor antagonists |
| 01/09/2003 | US20030008832 Method of inhibiting neoplastic cells with benzimidazole derivatives |
| 01/09/2003 | CA2451464A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 01/09/2003 | CA2451228A1 Novel heteroaryl derivatives, their preparation and use |
| 01/09/2003 | CA2451163A1 Agent for preventing or treating organ functional disorders and order dysfunction |
| 01/09/2003 | CA2451125A1 N-heterocyclic inhibitors of tnf-alpha expression |
| 01/09/2003 | CA2450982A1 New derivatives of oxazolidinones as antibacterial agents |
| 01/09/2003 | CA2450722A1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 01/09/2003 | CA2450686A1 Substituted 8-arylquinoline pde4 inhibitors |
| 01/08/2003 | EP1273573A1 Pyrazolylbenzylthioethers and their use for combating organisms which are harmful to plants |
| 01/08/2003 | EP1273572A1 Thiophene substituted piperazines useful in the treatment of benign prostatic hyperplasia |
| 01/08/2003 | EP1272487A1 Bicyclic heteroaryl compounds as inhibitors of the interaction between the integrin alpha4beta1 receptor and vcam-1 and/or fibronectin |
| 01/08/2003 | EP1272486A1 Method for producing 7-(pyrazole-3-yl) benzoxazoles |
| 01/08/2003 | EP1272485A1 Novel 1,2,3,4-tetrahydrosioquinoline, their preparation method and their use as fungicides |
| 01/08/2003 | EP1272484A2 Benzoamide piperidine compounds as substance p antagonists |
| 01/08/2003 | EP1272478A1 Substituted phenyluracils |